Prosthesis-patient mismatch (PPM) after surgical aortic valve replacement has become less common over time, but it remains associated with worsened clinical outcomes, a new study shows. Also, a second ...
CHICAGO, IL—Patients undergoing TAVR with a self-expanding supra-annular bioprothesis (CoreValve, Evolut R, or Evolut PRO; Medtronic) have lower aortic valve mean pressure gradients, larger effective ...
Choosing the optimal aortic valve prosthesis for middle-aged patients (late 40s to early 60s) with aortic stenosis presents a challenge. The available options all have substantial drawbacks that must ...
Prosthesis–patient mismatch (PPM) occurs when a prosthetic aortic valve with a smaller effective orifice area (EOA) than that of the patient's native valve is implanted. PPM results in abnormally high ...
Valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) for failed surgical valves was associated with similar or better procedural, 30-day, and 1-year outcomes compared with the "benchmark ...
WASHINGTON (May 16, 2016) --Patients with a combination of left ventricular dysfunction and low aortic valve gradient, or reduced force of blood flow through the aortic valve, have higher mortality ...
AUSTRALIA: Perceval S prosthesis is indicated for the replacement of a diseased native or a malfunctioning prosthetic aortic valve via open heart surgery. The prosthesis is indicated in patients who ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window CHICAGO -- Hemodynamics offers clues on which low-risk patients ...
Researchers may have found a way to boost the success of transcatheter aortic valve replacements, thanks to advances in 3-D printing technology. Share on Pinterest Researchers say that their ...
AUSTRALIA: Perceval S prosthesis is indicated for the replacement of a diseased native or a malfunctioning prosthetic aortic valve via open heart surgery. The prosthesis is indicated in patients who ...
PARIS -- The early commercial experience with transcatheter aortic valve replacement (TAVR or TAVI) for severe aortic regurgitation appeared promising, though device size issues and conduction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback